3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function. (Q47816087)

5 February 2018

title

3-4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function. (English)

1 reference

5 February 2018

author name string

R R Metzger

1

1 reference

5 February 2018

G R Hanson

2

1 reference

5 February 2018

J W Gibb

3

1 reference

5 February 2018

A E Fleckenstein

4

1 reference

5 February 2018

language of work or name

English

0 references

publication date

1 May 1998

1 reference

5 February 2018

European Journal of Pharmacology

published in

1 reference

5 February 2018

volume

349

1 reference

5 February 2018

issue

2-3

1 reference

5 February 2018

page(s)

205-210

1 reference

5 February 2018

Modification of dopamine transporter function: effect of reactive oxygen species and dopamine.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Superoxide radicals mediate the biochemical effects of methylenedioxymethamphetamine (MDMA): evidence from using CuZn-superoxide dismutase transgenic mice.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Extracellular dopamine in rat striatum following uptake inhibition by cocaine, nomifensine and benztropine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

The spin trap reagent alpha-phenyl-N-tert-butyl nitrone prevents 'ecstasy'-induced neurodegeneration of 5-hydroxytryptamine neurones

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Oxygen radicals diminish dopamine transporter function in rat striatum.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Estimating hydroxyl radical content in rat brain using systemic and intraventricular salicylate: impact of methamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Hyperlocomotion and indifference to cocaine and amphetamine in mice lacking the dopamine transporter

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Methcathinone: a new and potent amphetamine-like agent

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy").

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Methamphetamine-induced serotonin neurotoxicity is mediated by superoxide radicals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Behavioral, biochemical and neurotoxicological actions of the alpha-ethyl homologue of p-chloroamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Bromocriptine scavenges methamphetamine-induced hydroxyl radicals and attenuates dopamine depletion in mouse striatum

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Comparison of the release of [3H]dopamine from isolated corpus striatum by amphetamine, fenfluramine and unlabelled dopamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Microdialysis studies on 3,4-methylenedioxyamphetamine and structurally related analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Methylenedioxyamphetamine (MDA) and methylenedioxymethamphetamine (MDMA) cause selective ablation of serotonergic axon terminals in forebrain: immunocytochemical evidence for neurotoxicity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Nitric oxide inhibits [3H]dopamine uptake.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Reversal of the acute effects of 3,4-methylenedioxymethamphetamine by 5-HT uptake inhibitors.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

p-Chloroamphetamine releases both serotonin and dopamine into rat brain dialysates in vivo.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

The effects of 3,4-methylenedioxymethamphetamine (MDMA) and 3,4-methylenedioxyamphetamine (MDA) on monoaminergic systems in the rat brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Immediate and long-term effects of 3,4-methylenedioxymethamphetamine on serotonin pathways in brain of rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Acute inactivation of tryptophan hydroxylase by amphetamine analogs involves the oxidation of sulfhydryl sites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Reactive oxygen species inhibit high-affinity glutamate uptake: molecular mechanism and neuropathological implications.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

Long-lasting depletions of striatal dopamine and loss of dopamine uptake sites following repeated administration of methamphetamine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0014-2999%2898%2900196-4

10.1016/S0014-2999(98)00196-4

7 January 2021

Identifiers

DOI

1 reference

5 February 2018

PubMed ID

9671099

1 reference

5 February 2018